GlassScriptPhysician profile
Gary Reasor
NPI 1457356263
$9,048.00
in general payments reported to CMS, 2019-2025
23 companies · $626 in 2025
The $626 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,598 · 2020: $188 · 2021: $258 · 2022: $1,283 · 2023: $1,467 · 2024: $3,630 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,999 · Food and Beverage: $2,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,999.34 |
| Food and Beverage | $2,723.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,856.30 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Spinal Simplicity, LLC | $1,730.29 | 2022-2024 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,726.23 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $898.54 | 2019 | |
| Abbott Laboratories | $593.50 | 2019-2025 | Eterna, Proclaim |
| Si-Bone, INC. | $491.47 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $282.41 | 2022-2024 | Relistor |
| Spr Therapeutics, INC | $262.72 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $259.89 | 2019-2023 | Senza |
| Vertos Medical, INC. | $219.01 | 2019-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $211.23 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic USA, INC. | $125.23 | 2019 | |
| Avanos Medical | $72.79 | 2023-2025 | Coolief* Cooled Radiofrequency, Generator |
| Protega Pharmaceutials INC | $68.57 | 2023 | Roxybond |
| Flowonix Medical Incorporated | $62.18 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $58.92 | 2022 | |
| Globus Medical, INC. | $28.37 | 2025 | Senza |
| Smith+Nephew, INC. | $23.74 | 2023 | Pico 7, Renasys Go V2 Home, Renasys Touch |
| Bioventus LLC | $18.75 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.12 | 2021 | |
| Valinor Pharma, LLC | $14.84 | 2025 | Movantik |
| Blue Surgical LLC | $14.50 | 2024 | |
| Currax Pharmaceuticals LLC | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Reasor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.